MRI scans could offer new window into cystic fibrosis treatment effects
NCT ID NCT04391322
Summary
This study aims to see if MRI scans can detect changes in the lungs of people with cystic fibrosis who are receiving new CFTR-modulator treatments. Researchers will compare MRI results to standard breathing tests and quality of life measures over several years. The study includes healthy volunteers, people with stable cystic fibrosis, and those starting or receiving the new treatments, including a group of young children aged 4-8.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GROUP 1: HEALTHY CONTROLS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Hospital for Sick Children
Toronto, Ontario, M5G 1X8, Canada
Conditions
Explore the condition pages connected to this study.